In the same line, a meta-analysis conducted by Shlikpak et al. involving 11 general-population studies and five studies of chronic kidney disease cohorts showed that utilizing cystatin c independently or in addition to creatinine when calculating eGFR ameliorates the usage of eGFR to assess the risk of ESRD as well as death [58]. This evidence concerns the gene CST3 and chronic kidney disease.